跳转至内容
Merck
CN

R3904

逆转素

≥98% (HPLC), A3 adenosine receptor antagonist, solid

别名:

2-(4-吗啉代苯胺)-6-环己氨基嘌呤

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C21H27N7O
化学文摘社编号:
分子量:
393.49
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

逆转素, ≥98% (HPLC), solid

SMILES string

C1CCC(CC1)Nc2nc(Nc3ccc(cc3)N4CCOCC4)nc5nc[nH]c25

InChI

1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27)

InChI key

ZFLJHSQHILSNCM-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

solid

solubility

DMSO: soluble 7 mg/mL
H2O: insoluble

storage temp.

2-8°C

Quality Level

Gene Information

Application

逆转素已被用作单极纺锤体 1 (Mps1) 激酶抑制剂或有丝分裂纺锤体装配检查点 (SAC) 抑制剂:
  • 研究康普瑞汀 A4 (CA4) 介导的细胞毒性是否需要有丝分裂阻滞
  • 研究 SAC 活化对 eb 病毒 (EBV) 复制的贡献
  • 诱导染色体错分

Biochem/physiol Actions

逆转素是一种 A 3 腺苷受体拮抗剂、Aurora 激酶抑制剂和 Mps1 激酶抑制剂。
逆转素最早被描述为一种合成的取代嘌呤,具有去分化剂的活性;它被证明可以诱导分化的谱系定向细胞成为多潜能间充质干细胞 (MSCs)。还显示出具有强效、选择性人 a 3 腺苷受体拮抗剂的活性(K i 值为 0.66μl)。ATP-竞争性 Aurora 激酶抑制剂,Mps1 激酶抑制剂。此外,研究表明,逆转素是一种抗癌药物,可抑制多种癌细胞的生长并诱导其死亡。

Preparation Note

根据其他来源,在DMSO中储存的逆转溶液只能在短期内稳定冷藏。对于长期储存,等分试样应在-20°C下稳定保存最长2年。不建议溶液在常温下存放。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system
Santaguida S, et al.
Developmental Cell, 41(6), 638-651 (2017)
Xianlong Chen et al.
Journal of bone oncology, 46, 100601-100601 (2024-05-06)
Reversine, or 2-(4-morpholinoanilino)-6-cyclohexylaminopurine, is a 2,6-disubstituted purine derivative. This small molecule shows anti-tumor potential by playing a central role in the inhibition of several kinases related to cell cycle regulation and cytokinesis. In this study, systematic review demonstrated the feasibility
Haruna Ebisu et al.
Frontiers in pharmacology, 11, 620185-620185 (2021-02-16)
α/β-Tubulin inhibitors that alter microtubule (MT) dynamics are commonly used in cancer therapy, however, these inhibitors also cause severe side effects such as peripheral neuropathy. γ-Tubulin is a possible target as antitumor drugs with low side effects, but the antitumor
G N Subramanian et al.
Molecular human reproduction, 27(2) (2020-12-19)
Premature loss of ovarian activity before 40 years of age is known as primary ovarian insufficiency (POI) and occurs in ∼1% of women. A more subtle decline in ovarian activity, known as premature ovarian ageing (POA), occurs in ∼10% of women.
Krishna K Sarangapani et al.
The Journal of cell biology, 220(12) (2021-10-15)
Dividing cells detect and correct erroneous kinetochore-microtubule attachments during mitosis, thereby avoiding chromosome missegregation. The Aurora B kinase phosphorylates microtubule-binding elements specifically at incorrectly attached kinetochores, promoting their release and providing another chance for proper attachments to form. However, growing

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持